or Try an Advanced Search...

    Progressive Stocks List

    Symbol Grade Name % Change
    MIRM B Mirum Pharmaceuticals, Inc. 0.59
    CHX C ChampionX Corporation 1.09
    EXEL C Exelixis, Inc. -0.86
    BIIB C Biogen Idec Inc. -1.84
    ITT D ITT Corporation 0.00
    LRMR D Larimar Therapeutics, Inc. -1.04
    IGT D International Game Technology -0.89
    GLTO F Galecto, Inc. 9.95
    FULC F Fulcrum Therapeutics, Inc. 0.90
    View As Page of Charts
    Related Industries: Biotechnology Diversified Industrials Drug Manufacturers - Major Gambling Oil & Gas Equipment & Services
    Related Stock Lists: Biotechnology Medicine Cancer Disability Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pump Acid Aerospace Components Aerospace Market Alcohol Alzheimer's Disease Artificial Lift Equipment Asset Integrity Management Ataxia Autoimmune Disorders Automation Technologies Bearings Bile Acid Bingo

    Related ETFs - A few ETFs which own one or more of the above listed Progressive stocks.

    Symbol Grade Name Weight
    BIS D ProShares UltraShort Nasdaq Biotechnology 6.85
    FBT B First Trust Amex Biotech Index Fund 6.76
    BBP B BioShares Biotechnology Products Fund 5.18
    XES C SPDR S&P Oil & Gas Equipment & Services ETF 4.83
    MNTL B Tema Neuroscience and Mental Health ETF 4.68
    View all Progressive ETFs...
    Compare ETFs
    Compare BBP to MNTL Compare BIS to FBT Compare FBT to MNTL

        Progressive Stocks Recent News

        Date Stock Title
        Jul 3 ITT Should You Retain Markel Group (MKL) Stock in Your Portfolio?
        Jul 3 IGT IGT and Churchill Downs Incorporated Pioneer Historical Horse Racing ("HHR") in Malta with National Lottery plc
        Jul 2 BIIB Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
        Jul 2 BIIB US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments
        Jul 2 BIIB Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
        Jul 2 BIIB Biogen Completes Acquisition of Human Immunology Biosciences
        Jul 2 IGT International Game Technology PLC to Host Second Quarter 2024 Results Conference Call on Tuesday, July 30, 2024
        Jul 1 BIIB 10 clinical trials to watch in the second half of 2024
        Jun 28 MIRM MercadoLibre, A Few Other Growth Stocks, Among New Faces In IBD 50
        Jun 28 MIRM Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
        Jun 28 IGT Should You Hold International Games Technology (IGT) for the Long Term?
        Jun 28 BIIB Biogen, Eisai launch Alzheimer's drug Leqembi in China
        Jun 28 BIIB Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
        Jun 28 ITT Q1 Gas and Liquid Handling Earnings Review: First Prize Goes to Flowserve (NYSE:FLS)
        Jun 28 BIIB Eisai and Biogen launch Alzheimer's drug Leqembi in China
        Jun 27 BIIB “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
        Jun 27 EXEL The 23% return delivered to Exelixis' (NASDAQ:EXEL) shareholders actually lagged YoY earnings growth
        Jun 27 ITT Is It Too Late To Consider Buying ITT Inc. (NYSE:ITT)?
        Related Industries: Biotechnology Diversified Industrials Drug Manufacturers - Major Gambling Oil & Gas Equipment & Services
        Related Stock Lists: Biotechnology Medicine Cancer Disability Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pump Acid Aerospace Components Aerospace Market Alcohol Alzheimer's Disease Artificial Lift Equipment Asset Integrity Management Ataxia Autoimmune Disorders Automation Technologies Bearings Bile Acid Bingo
        Progressive

        Browse All Tags